August 7th, 2013
Cost Effectiveness of Cryptococcal Antigen Screening as a Strategy to Prevent HIV-Associated Cryptococcal Meningitis in South Africa
March 5th 2013
Highlights of the 20th Conference on Retroviruses and Opportunistic Infections (CROI) conference. Atlanta, GA, March 3-6 2013
April 16th, 2013
Alemu. A., S., Kempker. R., R., Tenna. A., et al.
Andama. A., O., S. den Boon. S. et al.
Meyer. A. -C., Kendi. C., K. et al.
January 25th, 2013
McMullan BJ, Halliday C, Sorrell TC, et al.
Clinical Utility of the Cryptococcal Antigen Lateral Flow Assay in a Diagnostic Mycology Laboratory
Binnicker MJ, Jespersen DJ, Bestrom JE, Rollins LO.
Comparison of four assays for the detection of cryptococcal antigen
Hansen J, Slechta ES, Gates-Hollingsworth MA, et al.
December 20th, 2012
New Southern African Society Cryptococcal Treatment Guidelines
Cryptococcal Screening Algorithm (December 2012)
African Society for Laboratory Medicine
Meya, D., Boulware,D. (2012 ). Cryptococcal Antigen Screening: Perspectives from Uganda
Govender, N.,P (2012). Cryptococcosis: Preventing a Deadly Fungal Disease Together.
Bauman, (2012) A Simple Method to Diagnose Cryptococcosis: CrAg LFA.
Graeme, M. ( 2012). Treatment of Cryptococcal Meningitis
Reconsidering Cryptococcal Antigen Screening in the U.S. among persons with CD4<100 cells/mcL
December 20th, 2012
African Society for Laboratory Medicine
Meya, D., Boulware,D. (2012 ). Cryptococcal Antigen Screening: Perspectives from Uganda
Govender, N.,P (2012). Cryptococcosis: Preventing a Deadly Fungal Disease Together.
Bauman, (2012) A Simple Method to Diagnose Cryptococcosis: CrAg LFA.
Graeme, M. ( 2012). Treatment of Cryptococcal Meningitis
December 8th, 2012
Govender, N., P., et al. South Africa Medical Journal Editorial, Dec. 2012.
Phased Implementation of Screening for Cryptococcal Disease in South Africa
National Institute for Communicable Diseases -Monthly Surveillance Report
Laboratory Based Screening for Cryptococcal Diseases
South African National Institute for Communicable Diseases -NHLS Communiqué November 2012
November 15, 2012
Highlights of the IDWeek 2012 Meeting – ”Advancing science, Improving care, San Francisco. Oct. 17-21, 2012.”
Oral: Invasion of the central nervous system by Cryptococcus neoformans requires a secreted fungal metalloprotease
Oral: Neurocognitive outcomes of cryptococcal meningitis in HIV-infected Ugandans
Poster : Customized Induction Therapy for the Treatment of Cryptococcal Meningitis Based on Initial Fungal Burden
Poster: Fluconazole resistance in cryptococcus neoformans: an emerging threat to the immune-compromised
Poster: Intraocular Pressure as a Non-Invasive Predictor for Increased Intracranial Pressure in Persons with Suspected or Confirmed Cryptococcal
Poster: Opportunistic Infections in Filipino HIV Patients
Poster: Outcomes of cryptococcal meningitis in HIV-infected patients at Chiang Mai University Hospital, Thailand
Poster: Test performance of a novel lateral-flow assay to detect Cryptococcal disease
For detailed conference information Click here
November 8, 2012
Highlights of the 52nd International Conference on Antimicrobial Agents and Infectious Diseases (ICAAC), San Francisco. Sept. 9-12, 2012, click here
Section: Cryptococcal Meningitis in Patients with AIDS: Clinical Experience in Tertiary care Teaching Hospital of Panama
Section: Prevalence of Cryptococcal Antigenemia and Cost Effectiveness of Cryptococcal Screening in Vietnam
Section: An Evaluation of Four Commercial Assays for the Detection of Cryptococcal Antigen
Section: Neurological, Visual, And MRI Brain Scan Findings in 87 South African Patients With HIV-associated Cryptococcal Meningeoencephalitis
Section: Multicenter Evaluation of Novel POC Assay for the Detection of Cryptococcal Antigen in HIV-Infected persons
For the full list of abstracts click here
November 1, 2012
Cryptococcal Disease and the new PEPFAR Technical Considerations:
Cryptococcal disease has recently been included in the Technical Considerations Provided by PEPFAR Technical Working Groups for FY 2013 COPS and ROPS, October 2012 (page 96,98 and 105). The Screening and treatment to prevent Cryptococcal Meningitis (CM) intervention (or approach) is now listed among the recommended Care and Support Services with supporting evidence of potential public health impact, particularly regarding morbidity and mortality.
For detailed information also available on the PEPFAR website: click here
October 28, 2012
The Antifungal Therapeutic effects of Sertraline in HIV-infected adults with Cryptococcal Meningitis: click here
Reconsidering Cryptococcal Antigen Screening in the U.S. among persons with CD4<100 cells/mcL: c lick Here
August 1, 2012
Highlights from the 2012 International AIDS Conference, Washington D.C., July 22-27
Session: Preventing Deaths from Cryptoccocal Meningitis: The South African Cryptococcal Screening Program
Session: New Strategies to Prevent Deaths from Cryptococcal Disease: A Workshop to Introduce New WHO Guidelines, New Rapid Dipstick Point-of-Care Testing, and New Strategies to Screen and Treat for Cryptococcosis
Oral: Cost benefit of integrating cryptococcal antigen screening and preemptive treatment into routine HIV care
Poster: The performance of serum cryptococcal antigen (CrAg) latex agglutination testing for diagnosis of cryptococcal meningitis (CM): a systematic review
Poster: Cost-effectiveness of cryptococcal meningitis treatment strategies in resource-limited settings
Poster: The role of lumbar puncture in the management of asymptomatic cryptococcemia prior to antiretroviral therapy initiation
For detailed conference information click here
June 12, 2012
Dr. Tom Frieden (@DrFriedenCDC) Tweeted about cryptococcal infection
[column size=”1-5″ last=”0″ style=”0″]
[/column][column size=”4-5″ last=”1″ style=”0″][quote style=”1″]Exciting progress diagnosing cryptococcal infection, fungus kills 500K/yr in Africa. Many of these deaths preventable. go.usa.gov/dtI[/quote][/column]
June 11, 2012
Surgeon General Dr. Regina Benjamin, reveals a personal history with cryptococcus
March 20, 2012
19th Conference on Retroviruses and Opportunistic Infections (CROI) Themed Discussion: Cryptococcal Meningitis: Advances in Diagnosis and Management. Seattle, Washington State Conference Center, March 5-8, 2012
For detailed conference information Click Here
WHO Guidelines – 2011
Rapid Advice: Diagnosis, Prevention and Management of Cryptococcal Disease in HIV-Infected Adults, Adolescents and Children
(2011, PDF, 0.539 MB) Read the WHO’s late-breaking recommendations on diagnosis, prevention and management of cryptococcal disease, including the utility of screening and pre-emptive therapy to reduce mortality caused by cryptococcosis.
